Opioids Market - Forecast(2024 - 2030)

Report Code: HCR 83189 Report Format: PDF + Excel

Opioids Market Overview:

The Opioids Market size is estimated to reach $620 Million by 2030, growing at a CAGR of 4% during the forecast period 2023-2030. The opioids market revolves around pharmaceutical products derived from opium, used primarily for pain management. Opioids act on the central nervous system's receptors to alleviate pain, but they also carry a risk of addiction and abuse. 

The market includes various forms such as prescription painkillers, synthetic opioids, and illicit drugs like heroin. Despite their effectiveness, concerns over opioid misuse have driven efforts to balance accessibility with safety.
 Regulatory measures, public health campaigns, and the development of abuse-deterrent formulations have shaped the market's dynamics. Opioid-related overdoses and addiction have also prompted increased attention on alternative pain management strategies and the expansion of addiction treatment services. As the market continues to evolve, stakeholders seek to strike a balance between addressing pain needs and mitigating the opioid epidemic's adverse effects.

Market Snapshot:

Opioids Market    - Report Coverage:

The “Opioids Market Report - Forecast (2023-2030)” by IndustryARC, covers an in-depth analysis of the following segments in the Opioids Market.

Attribute

Segment




BY PRODUCT TYPE

  • Methadone

  •  Codeine

  •  Fentanyl

  • Oxycodone

  •  Morphine

  •  Hydrocodone

  •  Others


BY APPLICATION

  • Pain Management,

  •  Cough Treatment

  •  Others

 

 

 



By Geography

  • North America (U.S., Canada and Mexico)

  • Europe (Germany, France, UK, Italy, Spain, Russia and Rest of Europe),

  • Asia-Pacific (China, Japan, South Korea, India, Australia & New Zealand and Rest of Asia-Pacific),

  •  South America (Brazil, Argentina, Chile, Colombia and Rest of South America)

  •  Rest of the World (Middle East and Africa).


Opioids Market - Top Trends Technological advancements: 

Abuse-Deterrent Formulations: Pharmaceutical companies are investing in the development of opioids with abuse-deterrent properties. These formulations make it more difficult for individuals to tamper with the medication to achieve a rapid and intense high, thereby reducing the risk of misuse.

Telemedicine and Digital Health: Telemedicine platforms and digital health solutions are being utilized to enhance pain management. Patients can consult healthcare providers remotely, receive prescription refills, and access personalized pain management plans, reducing the need for in-person visits and improving patient outcomes.

Precision Medicine: Advances in genetic and molecular research are enabling the exploration of precision medicine approaches for pain management. Tailoring opioid prescriptions based on individual genetic factors can optimize pain relief while minimizing the risk of adverse effects and addiction.

Big Data and Analytics: Healthcare providers are leveraging big data and analytics to identify patterns of opioid prescribing, usage, and abuse. This data-driven approach helps healthcare systems and policymakers make informed decisions to address the opioid epidemic.

Nanotechnology: Nanotechnology is being explored to create opioid formulations that release the medication gradually and target specific pain receptors, potentially reducing the risk of overdose and dependency.

Opioids Market - Company Product Analysis

Dosage Forms: Dosage Forms is available in various dosage forms, such as tablets, capsules, patches, or injectables, providing healthcare providers with flexibility in tailoring treatment to patients' needs.

Indications: Indications is indicated for the management of [specific pain conditions], catering to a wide range of patients experiencing different types of pain.

Dosing Regimen: The Dosing Regimen offers a dosing regimen that balances effective pain relief with minimizing potential side effects and risks associated with opioid therapy.

Patient Education: Patient Education offers comprehensive educational resources for patients and healthcare providers, including information about proper use, potential side effects, and responsible storage and disposal of opioids.

Formulation Innovation: Formulation Innovation has invested in developing formulations that enhance patient adherence and safety, including extended-release formulations or abuse-deterrent technologies.

Key Market Players: 

Product/Service launches, approvals, patents and events, acquisitions, partnerships and collaborations are key strategies adopted by players in the Opioids Market. The top 10 companies in this industry are listed below:
 

Report Metric

Details

Base Year Considered

2022

Forecast Period

2023–2030

CAGR

4%

Market Size in 2030

$620 Million

Segments Covered

By Treatment Type, Distribution Channel, Route of Administration, End User and Region





Geographies Covered

North America (U.S., Canada and Mexico), Europe (Germany, France, UK, Italy, Spain, Russia and Rest of Europe), Asia-Pacific (China, Japan, South Korea, India, Australia, New Zealand and Rest of Asia-Pacific), South America (Brazil, Argentina, Chile, Colombia and Rest of South America), Rest of the World (Middle East and Africa).






Key Market Players

  1. Purdue Pharma LP

  2.  AstraZeneca Plc.

  3. C.H. Boehringer Sohn Ag and Ko. Kg

  4. Johnson & Johnson, Inc..

  5. Sanofi S.A.

  6. Mallinckrodt Pharmaceuticals

  7.  V Endo Pharmaceuticals Inc

  8. Teva Pharmaceutical Industries Limited

  9.  Z Pfizer, Inc.

  10.  G Sun Pharmaceuticals


For more Lifesciences and Healthcare related reports, please click here
Table of Contents
1. Opioids Market - Overview
    1.1. Definitions and Scope
2. Opioids Market - Executive Summary
3. Opioids Market - Comparative Analysis
    3.1. Company Benchmarking - Key Companies
    3.2. Global Financial Analysis - Key Companies
    3.3. Market Share Analysis - Key Companies
    3.4. Patent Analysis
    3.5. Pricing Analysis
4. Opioids Market - Start-up Companies Scenario 
    4.1. Key Start-up Company Analysis by
    4.2. Investment
    4.3. Revenue
    4.4. Venture Capital and Funding Scenario
5. Opioids Market – Market Entry Scenario Premium 
    5.1. Regulatory Framework Overview
    5.2. New Business and Ease of Doing Business Index
    5.3. Case Studies of Successful Ventures
6. Opioids Market - Forces
    6.1. Market Drivers
    6.2. Market Constraints
    6.3. Market Challenges
    6.4. Porter's Five Force Model
    6.5. Bargaining Power of Suppliers
    6.6. Bargaining Powers of Customers
    6.7. Threat of New Entrants
    6.8. Rivalry Among Existing Players
    6.9. Threat of Substitutes
7. Opioids Market – Strategic Analysis
    7.1. Value Chain Analysis
    7.2. Opportunities Analysis
    7.3. Market Life Cycle
8. Opioids Market – BY PRODUCT TYPE (Market Size – $Million/$Billion) 
    8.1. Methadone 
        8.1.1.  Market Size and Forecast, By Region
        8.1.2.  Market Share Analysis, By Country
    8.2. A Codeine 
        8.2.1. Market Size and Forecast, By Region
        8.2.2. Market Share Analysis, By Country
    8.3. Fentanyl 
        8.3.1. Market Size and Forecast, By Region
        8.3.2. Market Share Analysis, By Country
    8.4. Oxycodone
        8.4.1. Market Size and Forecast, By Region
        8.4.2. Market Share Analysis, By Country
    8.5. Morphine
        8.5.1. Market Size and Forecast, By Region
        8.5.2. Market Share Analysis, By Country
    8.6. Hydrocodone
        8.6.1. Market Size and Forecast, By Region
        8.6.2. Market Share Analysis, By Country
9. Opioids Market – BY APPLICATION (Market Size – $Million/$Billion) 
    9.1. Pain Management
        9.1.1. Market Size and Forecast, By Region
        9.1.2. Market Share Analysis, By Country
    9.2. Cough Treatment
        9.2.1. Market Size and Forecast, By Region
        9.2.2. Market Share Analysis, By Country
    9.3. Diarrhea Treatment
        9.3.1. Market Size and Forecast, By Region
        9.3.2. Market Share Analysis, By Country
10. Opioids Market – by Geography (Market Size – $Million/$Billion) 
    10.1. North America
        10.1.1. The U.S.
        10.1.2. Canada
        10.1.3. Mexico
    10.2. Europe
        10.2.1. UK
        10.2.2. Germany
        10.2.3. France
        10.2.4. Italy
        10.2.5. Spain
        10.2.6. Russia
        10.2.7. Rest of Europe
    10.3. Asia-Pacific
        10.3.1. China
        10.3.2. India
        10.3.3. Japan
        10.3.4. South Korea
        10.3.5. Australia & New Zealand
        10.3.6. Rest of Asia-Pacific
    10.4. South America
        10.4.1. Brazil
        10.4.2. Argentina
        10.4.3. Chile
        10.4.4. Colombia
        10.4.5. Rest of South America
    10.5. Rest of the World
        10.5.1. Middle East
        10.5.2. Africa
11. Opioids Market – Entropy
12. Opioids Market – Industry/Segment Competition Landscape Premium 
    12.1. Market Share Analysis
        12.1.1. Market Share by Product Type – Key Companies
        12.1.2. Market Share by Region – Key Companies
        12.1.3. Market Share by Country – Key Companies
    12.2. Competition Matrix
    12.3. Best Practices for Companies
13. Opioids Market – Key Company List by Country Premium Premium 
14. Opioids Market - Company Analysis
    14.1. Purdue Pharma LP
    14.2. AstraZeneca Plc
    14.3. C.H. Boehringer Sohn Ag and Ko. Kg
    14.4. Johnson & Johnson, Inc..
    14.5. Sanofi S.A.
    14.6. Mallinckrodt Pharmaceuticals
    14.7. Endo Pharmaceuticals Inc
    14.8. Teva Pharmaceutical Industries Limited
    14.9. Pfizer, Inc.
    14.10. Sun Pharmaceuticals
    14.11. Hikma Pharmaceuticals PLC
    14.12. AbbVie Inc.
    14.13. Grünenthal
    14.14. Merck & Co., Inc.
    14.15. Boehringer Ingelheim international GmbH
    14.16. Janssen pharmaceuticals,inc.
    14.17. Mallinckrodt pharmaceuticals
    14.18. Endo pharmaceuticals inc.
    14.19. Assertio therapeutics, inc.
    14.20. Reckitt Benckiser Group plc
• "Financials to the Private Companies would be provided on best-effort basis."
Connect with our experts to get customized reports that best suit your requirements. Our 
reports include global-level data, niche markets and competitive landscape.

LIST OF TABLES

1.Global Opioids Market-Competitive Analysis Market 2019-2024 ($M)
1.1 Company/Competition Categorization Market 2019-2024 ($M) - Global Industry Research
1.1.1 List of key distributors and channel partners Market 2019-2024 ($M)
1.1.2 Key company market share analysis, Market 2019-2024 ($M)
1.2 Public Companies Market 2019-2024 ($M) - Global Industry Research
1.2.1 Company market share Market 2019-2024 ($M)
1.2.2 Synergy analysis:Major deals strategic alliances Market 2019-2024 ($M)
1.3 Private Companies Market 2019-2024 ($M) - Global Industry Research
1.3.1 List of key emerging companies Market 2019-2024 ($M)
2.Global Competitive Landscape Market 2019-2024 ($M)
2.1 Heat Map Analysis of Private Companies Market 2019-2024 ($M) - Global Industry Research
2.1.1 Company size Market 2019-2024 ($M)
2.1.2 Distribution network Market 2019-2024 ($M)
2.1.3 Segment coverage Market 2019-2024 ($M)
2.1.4 Geographic presence Market 2019-2024 ($M)
2.1.5 Collaborations Market 2019-2024 ($M)
2.2 Purdue Pharma L.P Market 2019-2024 ($M) - Global Industry Research
2.3 Janssen Pharmaceuticals, Inc. Market 2019-2024 ($M) - Global Industry Research
2.4 West-Ward Pharmaceuticals Corporation Market 2019-2024 ($M) - Global Industry Research
2.5 Pfizer, Inc. Market 2019-2024 ($M) - Global Industry Research
2.6 ALLERGAN Market 2019-2024 ($M) - Global Industry Research
2.7 Sanofi-Aventis S.A. Market 2019-2024 ($M) - Global Industry Research
2.8 Sun Pharmaceutical Industries Limited Market 2019-2024 ($M) - Global Industry Research
2.9 Grunenthal GmbH Market 2019-2024 ($M) - Global Industry Research
3.Global Opioids Market-Competitive Analysis Market 2019-2024 (Volume/Units)
3.1 Company/Competition Categorization Market 2019-2024 (Volume/Units) - Global Industry Research
3.1.1 List of key distributors and channel partners Market 2019-2024 (Volume/Units)
3.1.2 Key company market share analysis, Market 2019-2024 (Volume/Units)
3.2 Public Companies Market 2019-2024 (Volume/Units) - Global Industry Research
3.2.1 Company market share Market 2019-2024 (Volume/Units)
3.2.2 Synergy analysis:Major deals strategic alliances Market 2019-2024 (Volume/Units)
3.3 Private Companies Market 2019-2024 (Volume/Units) - Global Industry Research
3.3.1 List of key emerging companies Market 2019-2024 (Volume/Units)
4.Global Competitive Landscape Market 2019-2024 (Volume/Units)
4.1 Heat Map Analysis of Private Companies Market 2019-2024 (Volume/Units) - Global Industry Research
4.1.1 Company size Market 2019-2024 (Volume/Units)
4.1.2 Distribution network Market 2019-2024 (Volume/Units)
4.1.3 Segment coverage Market 2019-2024 (Volume/Units)
4.1.4 Geographic presence Market 2019-2024 (Volume/Units)
4.1.5 Collaborations Market 2019-2024 (Volume/Units)
4.2 Purdue Pharma L.P Market 2019-2024 (Volume/Units) - Global Industry Research
4.3 Janssen Pharmaceuticals, Inc. Market 2019-2024 (Volume/Units) - Global Industry Research
4.4 West-Ward Pharmaceuticals Corporation Market 2019-2024 (Volume/Units) - Global Industry Research
4.5 Pfizer, Inc. Market 2019-2024 (Volume/Units) - Global Industry Research
4.6 ALLERGAN Market 2019-2024 (Volume/Units) - Global Industry Research
4.7 Sanofi-Aventis S.A. Market 2019-2024 (Volume/Units) - Global Industry Research
4.8 Sun Pharmaceutical Industries Limited Market 2019-2024 (Volume/Units) - Global Industry Research
4.9 Grunenthal GmbH Market 2019-2024 (Volume/Units) - Global Industry Research
5.North America Opioids Market-Competitive Analysis Market 2019-2024 ($M)
5.1 Company/Competition Categorization Market 2019-2024 ($M) - Regional Industry Research
5.1.1 List of key distributors and channel partners Market 2019-2024 ($M)
5.1.2 Key company market share analysis, Market 2019-2024 ($M)
5.2 Public Companies Market 2019-2024 ($M) - Regional Industry Research
5.2.1 Company market share Market 2019-2024 ($M)
5.2.2 Synergy analysis:Major deals strategic alliances Market 2019-2024 ($M)
5.3 Private Companies Market 2019-2024 ($M) - Regional Industry Research
5.3.1 List of key emerging companies Market 2019-2024 ($M)
6.North America Competitive Landscape Market 2019-2024 ($M)
6.1 Heat Map Analysis of Private Companies Market 2019-2024 ($M) - Regional Industry Research
6.1.1 Company size Market 2019-2024 ($M)
6.1.2 Distribution network Market 2019-2024 ($M)
6.1.3 Segment coverage Market 2019-2024 ($M)
6.1.4 Geographic presence Market 2019-2024 ($M)
6.1.5 Collaborations Market 2019-2024 ($M)
6.2 Purdue Pharma L.P Market 2019-2024 ($M) - Regional Industry Research
6.3 Janssen Pharmaceuticals, Inc. Market 2019-2024 ($M) - Regional Industry Research
6.4 West-Ward Pharmaceuticals Corporation Market 2019-2024 ($M) - Regional Industry Research
6.5 Pfizer, Inc. Market 2019-2024 ($M) - Regional Industry Research
6.6 ALLERGAN Market 2019-2024 ($M) - Regional Industry Research
6.7 Sanofi-Aventis S.A. Market 2019-2024 ($M) - Regional Industry Research
6.8 Sun Pharmaceutical Industries Limited Market 2019-2024 ($M) - Regional Industry Research
6.9 Grunenthal GmbH Market 2019-2024 ($M) - Regional Industry Research
7.South America Opioids Market-Competitive Analysis Market 2019-2024 ($M)
7.1 Company/Competition Categorization Market 2019-2024 ($M) - Regional Industry Research
7.1.1 List of key distributors and channel partners Market 2019-2024 ($M)
7.1.2 Key company market share analysis, Market 2019-2024 ($M)
7.2 Public Companies Market 2019-2024 ($M) - Regional Industry Research
7.2.1 Company market share Market 2019-2024 ($M)
7.2.2 Synergy analysis:Major deals strategic alliances Market 2019-2024 ($M)
7.3 Private Companies Market 2019-2024 ($M) - Regional Industry Research
7.3.1 List of key emerging companies Market 2019-2024 ($M)
8.South America Competitive Landscape Market 2019-2024 ($M)
8.1 Heat Map Analysis of Private Companies Market 2019-2024 ($M) - Regional Industry Research
8.1.1 Company size Market 2019-2024 ($M)
8.1.2 Distribution network Market 2019-2024 ($M)
8.1.3 Segment coverage Market 2019-2024 ($M)
8.1.4 Geographic presence Market 2019-2024 ($M)
8.1.5 Collaborations Market 2019-2024 ($M)
8.2 Purdue Pharma L.P Market 2019-2024 ($M) - Regional Industry Research
8.3 Janssen Pharmaceuticals, Inc. Market 2019-2024 ($M) - Regional Industry Research
8.4 West-Ward Pharmaceuticals Corporation Market 2019-2024 ($M) - Regional Industry Research
8.5 Pfizer, Inc. Market 2019-2024 ($M) - Regional Industry Research
8.6 ALLERGAN Market 2019-2024 ($M) - Regional Industry Research
8.7 Sanofi-Aventis S.A. Market 2019-2024 ($M) - Regional Industry Research
8.8 Sun Pharmaceutical Industries Limited Market 2019-2024 ($M) - Regional Industry Research
8.9 Grunenthal GmbH Market 2019-2024 ($M) - Regional Industry Research
9.Europe Opioids Market-Competitive Analysis Market 2019-2024 ($M)
9.1 Company/Competition Categorization Market 2019-2024 ($M) - Regional Industry Research
9.1.1 List of key distributors and channel partners Market 2019-2024 ($M)
9.1.2 Key company market share analysis, Market 2019-2024 ($M)
9.2 Public Companies Market 2019-2024 ($M) - Regional Industry Research
9.2.1 Company market share Market 2019-2024 ($M)
9.2.2 Synergy analysis:Major deals strategic alliances Market 2019-2024 ($M)
9.3 Private Companies Market 2019-2024 ($M) - Regional Industry Research
9.3.1 List of key emerging companies Market 2019-2024 ($M)
10.Europe Competitive Landscape Market 2019-2024 ($M)
10.1 Heat Map Analysis of Private Companies Market 2019-2024 ($M) - Regional Industry Research
10.1.1 Company size Market 2019-2024 ($M)
10.1.2 Distribution network Market 2019-2024 ($M)
10.1.3 Segment coverage Market 2019-2024 ($M)
10.1.4 Geographic presence Market 2019-2024 ($M)
10.1.5 Collaborations Market 2019-2024 ($M)
10.2 Purdue Pharma L.P Market 2019-2024 ($M) - Regional Industry Research
10.3 Janssen Pharmaceuticals, Inc. Market 2019-2024 ($M) - Regional Industry Research
10.4 West-Ward Pharmaceuticals Corporation Market 2019-2024 ($M) - Regional Industry Research
10.5 Pfizer, Inc. Market 2019-2024 ($M) - Regional Industry Research
10.6 ALLERGAN Market 2019-2024 ($M) - Regional Industry Research
10.7 Sanofi-Aventis S.A. Market 2019-2024 ($M) - Regional Industry Research
10.8 Sun Pharmaceutical Industries Limited Market 2019-2024 ($M) - Regional Industry Research
10.9 Grunenthal GmbH Market 2019-2024 ($M) - Regional Industry Research
11.APAC Opioids Market-Competitive Analysis Market 2019-2024 ($M)
11.1 Company/Competition Categorization Market 2019-2024 ($M) - Regional Industry Research
11.1.1 List of key distributors and channel partners Market 2019-2024 ($M)
11.1.2 Key company market share analysis, Market 2019-2024 ($M)
11.2 Public Companies Market 2019-2024 ($M) - Regional Industry Research
11.2.1 Company market share Market 2019-2024 ($M)
11.2.2 Synergy analysis:Major deals strategic alliances Market 2019-2024 ($M)
11.3 Private Companies Market 2019-2024 ($M) - Regional Industry Research
11.3.1 List of key emerging companies Market 2019-2024 ($M)
12.APAC Competitive Landscape Market 2019-2024 ($M)
12.1 Heat Map Analysis of Private Companies Market 2019-2024 ($M) - Regional Industry Research
12.1.1 Company size Market 2019-2024 ($M)
12.1.2 Distribution network Market 2019-2024 ($M)
12.1.3 Segment coverage Market 2019-2024 ($M)
12.1.4 Geographic presence Market 2019-2024 ($M)
12.1.5 Collaborations Market 2019-2024 ($M)
12.2 Purdue Pharma L.P Market 2019-2024 ($M) - Regional Industry Research
12.3 Janssen Pharmaceuticals, Inc. Market 2019-2024 ($M) - Regional Industry Research
12.4 West-Ward Pharmaceuticals Corporation Market 2019-2024 ($M) - Regional Industry Research
12.5 Pfizer, Inc. Market 2019-2024 ($M) - Regional Industry Research
12.6 ALLERGAN Market 2019-2024 ($M) - Regional Industry Research
12.7 Sanofi-Aventis S.A. Market 2019-2024 ($M) - Regional Industry Research
12.8 Sun Pharmaceutical Industries Limited Market 2019-2024 ($M) - Regional Industry Research
12.9 Grunenthal GmbH Market 2019-2024 ($M) - Regional Industry Research
13.MENA Opioids Market-Competitive Analysis Market 2019-2024 ($M)
13.1 Company/Competition Categorization Market 2019-2024 ($M) - Regional Industry Research
13.1.1 List of key distributors and channel partners Market 2019-2024 ($M)
13.1.2 Key company market share analysis, Market 2019-2024 ($M)
13.2 Public Companies Market 2019-2024 ($M) - Regional Industry Research
13.2.1 Company market share Market 2019-2024 ($M)
13.2.2 Synergy analysis:Major deals strategic alliances Market 2019-2024 ($M)
13.3 Private Companies Market 2019-2024 ($M) - Regional Industry Research
13.3.1 List of key emerging companies Market 2019-2024 ($M)
14.MENA Competitive Landscape Market 2019-2024 ($M)
14.1 Heat Map Analysis of Private Companies Market 2019-2024 ($M) - Regional Industry Research
14.1.1 Company size Market 2019-2024 ($M)
14.1.2 Distribution network Market 2019-2024 ($M)
14.1.3 Segment coverage Market 2019-2024 ($M)
14.1.4 Geographic presence Market 2019-2024 ($M)
14.1.5 Collaborations Market 2019-2024 ($M)
14.2 Purdue Pharma L.P Market 2019-2024 ($M) - Regional Industry Research
14.3 Janssen Pharmaceuticals, Inc. Market 2019-2024 ($M) - Regional Industry Research
14.4 West-Ward Pharmaceuticals Corporation Market 2019-2024 ($M) - Regional Industry Research
14.5 Pfizer, Inc. Market 2019-2024 ($M) - Regional Industry Research
14.6 ALLERGAN Market 2019-2024 ($M) - Regional Industry Research
14.7 Sanofi-Aventis S.A. Market 2019-2024 ($M) - Regional Industry Research
14.8 Sun Pharmaceutical Industries Limited Market 2019-2024 ($M) - Regional Industry Research
14.9 Grunenthal GmbH Market 2019-2024 ($M) - Regional Industry Research

LIST OF FIGURES

1.US Opioids Market Revenue, 2019-2024 ($M)
2.Canada Opioids Market Revenue, 2019-2024 ($M)
3.Mexico Opioids Market Revenue, 2019-2024 ($M)
4.Brazil Opioids Market Revenue, 2019-2024 ($M)
5.Argentina Opioids Market Revenue, 2019-2024 ($M)
6.Peru Opioids Market Revenue, 2019-2024 ($M)
7.Colombia Opioids Market Revenue, 2019-2024 ($M)
8.Chile Opioids Market Revenue, 2019-2024 ($M)
9.Rest of South America Opioids Market Revenue, 2019-2024 ($M)
10.UK Opioids Market Revenue, 2019-2024 ($M)
11.Germany Opioids Market Revenue, 2019-2024 ($M)
12.France Opioids Market Revenue, 2019-2024 ($M)
13.Italy Opioids Market Revenue, 2019-2024 ($M)
14.Spain Opioids Market Revenue, 2019-2024 ($M)
15.Rest of Europe Opioids Market Revenue, 2019-2024 ($M)
16.China Opioids Market Revenue, 2019-2024 ($M)
17.India Opioids Market Revenue, 2019-2024 ($M)
18.Japan Opioids Market Revenue, 2019-2024 ($M)
19.South Korea Opioids Market Revenue, 2019-2024 ($M)
20.South Africa Opioids Market Revenue, 2019-2024 ($M)
21.North America Opioids By Application
22.South America Opioids By Application
23.Europe Opioids By Application
24.APAC Opioids By Application
25.MENA Opioids By Application

The Motion Sickness Treatment is forecast to grow at 4% during the forecast period 2023-2030.

Global Opioids Market size is estimated to reach $620 Million by 2030.

The leading players in the Opioids Market are Purdue Pharma LP, AstraZeneca Plc., C.H. Boehringer Sohn Ag and Ko. Kg , Johnson & Johnson, Inc.., Sanofi S.A.